Kris Maynard, like many, was initially shocked when he was diagnosed with Type 1 Diabetes in 1999. He was clueless about diabetes at the time and figured he was experiencing Couvade Syndrome, a condition in which a man goes through similar symptoms of his pregnant spouse. Maynard’s wife was pregnant at the time and he summed up the frequent, late-night trips to the bathroom as an indicator of couvade. It wasn’t Couvade Syndrome but diabetes.
The diagnosis rattled Maynard’s livelihood as he was in the military at the time and was kicked out after four years, due to his chronic condition. Maynard immediately went on to become a firefighter in 2000. It was in 2005 that he experienced his first low blood sugar at the fire station. Despite meeting the physical requirements, Maynard was told he was a “safety” concern to other crew members and consequently, lost his job as a firefighter. The reasoning was if he were to encounter having low blood sugar while fighting fire, his crew members would have to “rescue” him.
The setbacks served as further inspiration for Maynard who started his business, Glucose Revival, https://glucoserevival.com/ an online store that sells merchandise such as medical alert necklaces for people with diabetes. “My insulin pump, CGM, and Thrive necklace were the “new,” tools needed to help get my firefighter job back. Glucagon is the only approved drug for severe low blood sugars whereas Thrive Glucose, our necklace can be used for any level of low blood sugar whether minor, moderate, or severe.” Last year, when COVID-19 made its mark in the U.S., Maynard donated $70,000 worth of Glucose Revival products to healthcare workers with diabetes.
Maynard, a father of two boys, is determined to help those in the diabetes community. His younger son, David, who is now 18, took an antibodies test that revealed David has two of the five indicators that lead to Type 1 diabetes. His older son, Josh, does not have any indicators of the condition. “It scares me knowing that my kid is going to have diabetes. I don’t think enough is being done,” said Maynard.
Maynard is passionate about helping to provide cost-effective resources to help those in the diabetes community. “Thrive glucose is a glucose gel that most EMTs are trained to use, not Glucagon. Glucagon is an injection that 75% of EMTs cannot administer. 80% of diabetics do not carry Glucagon because it costs $250 and expires. We want 100% of people with diabetes to be protected.”